Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1BIIB019 (Daclizumab High Yield Process)1件: Daclizumab (Dacliximab)1件: Daclizumab (Daclizumab) 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
2BIIB019 (Daclizumab)1件: Daclizumab (Dacliximab)1件: Daclizumab (Daclizumab) 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
3DAC----1件: 13 💬
4DAC HYP----1件: 13 💬
5DAC-HYP----1件: 13 💬
6Dacepton 5 mg/ml----1件: 6 💬
7Dacepton 5 mg/ml infuusioneste, liuos----1件: 6 💬
8DACLIZUMAB1件: Daclizumab (Dacliximab)1件: Daclizumab (Daclizumab) 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬8件: 13, 56, 60, 65, 97, 107, 283, 284 💬
9Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)1件: Daclizumab (Dacliximab)1件: Daclizumab (Daclizumab) 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
10Daclizumab High Yield Process1件: Daclizumab (Dacliximab)1件: Daclizumab (Daclizumab) 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
11DACLIZUMAB HYP1件: Daclizumab (Dacliximab)1件: Daclizumab (Daclizumab) 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
12Daclizumab HYP (DAC HYP1件: Daclizumab (Dacliximab)1件: Daclizumab (Daclizumab) 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
13Daclizumab HYP (DAC HYP)1件: Daclizumab (Dacliximab)1件: Daclizumab (Daclizumab) 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
14Daclizumab wih Greek suffix1件: Daclizumab (Dacliximab)1件: Daclizumab (Daclizumab) 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
15Daclizumab with Greek suufix1件: Daclizumab (Dacliximab)1件: Daclizumab (Daclizumab) 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
16DACORTIN----1件: 97 💬
17Dacortin ®----1件: 46 💬
18Dacortín 2,5mg----1件: 222 💬
19Dacortín 30mg----1件: 222 💬
20Dacortín 5mg----1件: 222 💬
21Decitabine
(Dacogen)		1件: Decitabine (Dacogen)1件: Decitabine (Dacogen) 💬 3件: DNMT1,
DNMT3A,
DNMT3B 💬 		3件: Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer 💬2件: 60, 63 💬